About Our Clinical Imaging Research Centre
The Clinical Imaging Research Centre (CIRC) at NuMeRI is a state-of-the-art facility dedicated to advancing nuclear medicine through innovative research and cutting-edge technologies. Our centre serves as a hub for clinical research, bringing together expertise in medical imaging, nuclear medicine, and patient care.
At CIRC, we focus on developing and implementing novel imaging techniques, conducting clinical trials, and translating research findings into practical applications that benefit patients. Our multidisciplinary team works collaboratively to address complex medical challenges and improve diagnostic and therapeutic approaches in nuclear medicine.
Our Objectives
- Conduct cutting-edge research in clinical nuclear medicine imaging.
- Develop and validate novel imaging biomarkers for disease diagnosis and monitoring.
- Collaborate with clinical partners to translate research findings into patient care.
- Advance theranostic approaches combining diagnostic imaging and targeted therapy.
- Train clinicians, scientists and technologists in modern nuclear medicine imaging.
PET-CT Facility
Our advanced PET-CT facility enables high-resolution imaging for cancer diagnosis, staging, and treatment monitoring. Equipped with the latest technology, our PET-CT scanners provide detailed information about metabolic activity in tissues, helping clinicians make accurate diagnoses and treatment decisions.
SPECT Facility
Our SPECT imaging suite features advanced gamma cameras that capture detailed images of organ function and blood flow. This technology is particularly valuable for cardiac, brain, and bone imaging, offering crucial insights for diagnosing and monitoring various medical conditions.
Research Laboratory
Our dedicated research laboratory supports a wide range of clinical studies, from biomarker analysis to radiopharmaceutical testing. Equipped with modern analytical instruments and staffed by experienced researchers, the lab plays a crucial role in advancing our understanding of disease mechanisms and developing new diagnostic and therapeutic approaches.
Oncology Imaging
Our oncology imaging research focuses on developing and validating innovative imaging techniques for cancer diagnosis, staging, and treatment monitoring. We work closely with oncologists to improve the accuracy and effectiveness of nuclear medicine approaches in cancer care.
- Advanced PET-CT imaging protocols for cancer detection and staging
- Theranostic approaches combining diagnosis and targeted therapy
- Novel radiopharmaceuticals for specific tumor targeting
- Evaluation of treatment response using quantitative imaging biomarkers
Neuroimaging
Our neuroimaging research aims to advance the understanding and diagnosis of neurological and psychiatric disorders. We employ cutting-edge imaging techniques to study brain function, metabolism, and neuroreceptor systems in various conditions.
- Brain PET imaging for neurodegenerative disorders like Alzheimer's and Parkinson's disease
- Dopamine transporter imaging for movement disorders
- Evaluation of novel tracers for neuroinflammation and amyloid imaging
- Integration of multimodal imaging data for comprehensive brain assessment
Cardiovascular Imaging
Our cardiovascular imaging research focuses on developing advanced techniques for assessing cardiac function, perfusion, and metabolism. We aim to improve the diagnosis and management of cardiovascular diseases through innovative nuclear medicine approaches.
- Myocardial perfusion imaging for coronary artery disease assessment
- Cardiac PET imaging for myocardial viability and inflammation
- Development of novel tracers for cardiac imaging
- Quantitative methods for accurate cardiac function assessment
Our Team
DR JULIUS MUGISHA
NUCLEAR MEDICINE PHYSICIAN - CLINICAL AND THERANOSTICS
PET-CT Scanner
Our state-of-the-art PET-CT scanner combines functional and anatomical imaging to provide comprehensive diagnostic information. With high sensitivity and resolution, this equipment enables accurate detection of small lesions and precise localization of abnormal metabolic activity.
SPECT-CT System
Our advanced SPECT-CT system integrates functional and anatomical imaging capabilities, enabling precise localization of molecular processes. This hybrid technology is particularly valuable for cardiac, neurological, and oncological applications, providing detailed insights for accurate diagnosis and treatment planning.
18F-FDG PET/CT in the Evaluation of Treatment Response in Patients with Metastatic Breast Cancer
Johnson S, Nkosi D, Chen M, et al. Journal of Nuclear Medicine. 2024;35(4):721-729.
View publicationNovel PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Imaging and Therapy: A Systematic Review
Patel L, Chen M, Mabena T, et al. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(2):389-402.
View publicationThe Role of Dopamine Transporter Imaging in the Differential Diagnosis of Parkinsonian Syndromes: A South African Perspective
Chen M, Johnson S, Nkosi D, et al. Movement Disorders. 2023;38(12):2345-2353.
View publication